Amalgamated Bank Rallybio Corp Transaction History

Amalgamated Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$1.25 - $2.4 $2,045 - $3,926	-1,636 Reduced 74.53%	559 $1,000
Q4 2023 Feb 06, 2024	SELL	$1.91 - $4.39 $317 - $728	-166 Reduced 7.03%	2,195 $5,000
Q2 2023 Aug 11, 2023	BUY	$4.31 - $8.89 $21 - $44	5 Added 0.21%	2,361 $13,000
Q1 2023 May 02, 2023	SELL	$4.37 - $8.75 $406 - $813	-93 Reduced 3.8%	2,356 $13,000
Q3 2022 Nov 09, 2022	BUY	$7.54 - $14.56 $226 - $436	30 Added 1.24%	2,449 $35,000
Q2 2022 Aug 15, 2022	BUY	$6.26 - $13.65 $8,507 - $18,550	1,359 Added 128.21%	2,419 $18,000
Q1 2022 Jun 30, 2022	BUY	$6.91 - $15.04 $7,324 - $15,942	1,060 New	1,060 $7,000

31.9M

Ticker RLYB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,132,000
Market Cap $30.5M
Description
Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.